History of EGL Genetic Diagnostics LLC

In 1970, Emory University established the company as an academic, not-for-profit organization, with the mission of performing biochemical, cytogenetics, and molecular clinical genetic testing. Since its inception, the company has served as the only comprehensive provider of clinical and laboratory genetic services in Georgia. In January 1991, we achieved our first major growth milestone by expanding our molecular laboratory to explore improving technologies and advancements in DNA testing.

The three laboratories continued to operate under the Emory Department of Pediatrics until 2002, when Stephen Warren, PhD, FACMG, incorporated the company into the newly created Emory Department of Human Genetics, which he founded. Emory University’s Department of Human Genetics, performs research, teaching, and clinical services for the School of Medicine, and is home to the National Down Syndrome Project. It also serves as one of only three national Fragile X research centers. In 2004, the company, including its biochemical, cytogenetics, and molecular laboratories, were fully integrated into a single location. 

In 2015, Emory University entered into a joint venture with Eurofins Scientific whereby Eurofins acquired a controlling interest in the company, which was renamed EGL Genetic Diagnostics LLC.  In 2017, EGL moved to its current location in Tucker, Georgia.  The facility is a 65,000 square foot, purpose-built state-of-the art, Biological Safety Level II laboratory facility, located on the northeast side of the Atlanta metropolitan area.

EGL currently employs greater than 100 staff members and is led by a highly experienced and knowledgeable team of laboratory directors, who are pioneers in the field of human genetics. Their expertise spans the fields of molecular biology, cytogenetics, biochemical genetics, rare-disease testing, and comprehensive testing for newborn screening follow-up.  EGL is the first clinical laboratory to contribute to the “Free the data” movement, by giving the clinical and research community open-access to its online variant (mutation) database. The company also serves as the follow-up laboratory for the state of Georgia Newborn Screening Program

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.